Brand Name
Baxdela
Generic Name
Delafloxacin Meglumine
View Brand Information FDA approval date: June 19, 2017
Classification: Fluoroquinolone Antibacterial
Form: Injection, Tablet
What is Baxdela (Delafloxacin Meglumine)?
BAXDELA is a fluoroquinolone antibacterial indicated for the treatment of adults with the following infections caused by designated susceptible bacteria: Acute Bacterial Skin and Skin Structure Infections .
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment